Ascendis Pharma A/S Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-15: Form 6-K; Period of report 2026-09-14; Description 6-K; Document d183438d6k.htm.
- 2026-09-15: Form 6-K; Period of report 2026-09-14; Description 6-K; Document d52763d6k.htm.
- 2026-09-09: Form 6-K; Period of report 2026-09-09; Description 6-K; Document d152057d6k.htm.
- 2026-09-09: Form 6-K; Period of report 2026-09-09; Description 6-K; Document d32116d6k.htm.